CFO of Keryx Biopharmaceuticals Inc. (KERX, Financial) James F Iii Oliviero sells 7,190 shares of KERX on 01/03/2012 at an average price of $2.63 a share.
Keryx Biopharmaceuticals Inc. has a market cap of $188.2 million; its shares were traded at around $2.65 with and P/S ratio of 7.5.
For the complete insider trading history of KERX, click here.
Keryx Biopharmaceuticals Inc. has a market cap of $188.2 million; its shares were traded at around $2.65 with and P/S ratio of 7.5.
CEO Recent Trades:
- CEO Ron Bentsur bought 7,500 shares of KERX stock on 08/10/2011 at the average price of 3.05. Ron Bentsur owns at least 359,281 shares after this. The price of the stock has decreased by 13.11% since.
Directors and Officers Recent Trades:
- Director Wyche Jr Fowler bought 5,000 shares of KERX stock on 08/10/2011 at the average price of 3.07. Wyche Jr Fowler owns at least 125,000 shares after this. The price of the stock has decreased by 13.68% since.
- Director Joseph M Feczko bought 10,000 shares of KERX stock on 08/10/2011 at the average price of 3.09. Joseph M Feczko owns at least 50,000 shares after this. The price of the stock has decreased by 14.24% since.
- Director Michael P. Tarnok bought 15,000 shares of KERX stock on 08/10/2011 at the average price of 3.1. Michael P. Tarnok owns at least 261,100 shares after this. The price of the stock has decreased by 14.52% since.
For the complete insider trading history of KERX, click here.
